Reducing the Burden of Hepatocellular Carcinoma Among Migrant Populations: Improving prevention and outcomes through disease modeling
Reducing the Burden of Hepatocellular Carcinoma Among Migrant Populations: Improving prevention and outcomes through disease modeling
批准号:
10558568
负责人:
Kenneth Andrew Valles
金额:
$5.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-02-01 至 2025-01-31
关键词:
AffectAgeAmericanCancer EtiologyCessation of lifeCharacteristicsChronicChronic viral hepatitisCommunitiesCost-Benefit AnalysisCountryDataData SetDetectionDevelopmentDiseaseDisease ProgressionDisease modelEnsureEpidemicEuropeEuropeanEuropean UnionFailureFutureGenerationsGoalsGuidelinesHIVHealthHealth PolicyHepatitisHepatitis B InfectionHepatitis C virusImmigrantImmigrationIncidenceIndividualInfectionKnowledgeLengthLiver CirrhosisLong-Term CareMalariaMalignant NeoplasmsMalignant neoplasm of liverMeasuresMental disordersMigrantModelingModificationMorbidity - disease rateOutcomePatient CarePatientsPersonsPoliciesPolicy MakerPopulationPopulation StatisticsPrevalencePreventionPrimary carcinoma of the liver cellsProcessRecordsResearchRiskSeveritiesSwedenTestingTreatment CostTuberculosisUnited StatesVaccinationViral hepatitisWorld Health Organizationage groupburden of illnesscomorbiditydata registrydemographicsdisease disparitydisorder riskend stage liver diseaseepidemiologic dataexperiencehealth datahealth managementhuman migrationimprovedinnovationliver inflammationlow income countrymigrationmortalitypoor health outcomepreventable deathprogramsrisk stratificationroutine screeningscreeningscreening policy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer mortality in the United States. HCC is
preventable, and it disproportionately affects migrants with unrecognized asymptomatic Chronic Viral Hepatitis
(CVH). The long-term goal of this project is to reduce the occurrence of preventable liver cancer in migrant
populations. The overall objective of this proposal is to estimate the Chronic Viral Hepatitis (CVH) and
Hepatocellular Carcinoma (HCC) prevalence among migrants, to detect key identifiers associated with high-
burden groups, and to describe the comorbidities and outcomes of those groups. The purpose of achieving this
goal is to reduce the occurrence of preventable liver cancer in migrant populations. This study will contribute to
this through the generation of the epidemiological data required for patients, practitioners, and policymakers
alike to more readily identify the migrant groups that would benefit most from strategic screening and
surveillance.
The central hypothesis is that HCC and CVH risk and outcomes among migrants can be estimated by
demographics. This will be tested by pursuing two specific aims: 1) Establish prevalence of CVH and HCC
among migrant populations; and 2) Identify CVH and HCC comorbidities and outcomes within the migrant
population. Under the first aim, a proven CVH and HCC disease model will be paired with migrant population
statistics to establish the risk profiles for distinct migrant populations, including age group and country-of-origin.
Under the second aim, an existing retrospective, population-wide health dataset will be utilized to identify
common concomitant disease and outcomes among distinct migrant populations. The proposed research is
innovative because it focuses on identifying key characteristics unique to specific migrant populations and
establishing the associated CVH and HCC risk profiles. If achieved, the results are expected to be significant
because they will contribute to resolving the current knowledge gaps in the disease burden and disparities of
distinct migrant populations, allowing for risk stratifying and appropriate modifications to impact screening
policy and practice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reducing the Burden of Hepatocellular Carcinoma Among Migrant Populations: Improving prevention and outcomes through disease modeling
-
批准号:10331002
-
项目类别:
-
资助金额:$4.7万
-
财政年份:2021
-
负责人:Kenneth Andrew Valles
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: